These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 33009446)

  • 41. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S; Carmosino M; Gerbino A; Svelto M; Procino G
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29125546
    [TBL] [Abstract][Full Text] [Related]  

  • 42. AVPR2 variants and V2 vasopressin receptor function in nephrogenic diabetes insipidus.
    Wildin RS; Cogdell DE; Valadez V
    Kidney Int; 1998 Dec; 54(6):1909-22. PubMed ID: 9853256
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrogenic diabetes insipidus.
    Bichet DG
    Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relief of nocturnal enuresis by desmopressin is kidney and vasopressin type 2 receptor independent.
    Robben JH; Sze M; Knoers NV; Eggert P; Deen P; Müller D
    J Am Soc Nephrol; 2007 May; 18(5):1534-9. PubMed ID: 17389737
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
    Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Functional characterization of vasopressin receptor 2 mutations causing partial and complete congenital nephrogenic diabetes insipidus in Thai families.
    Sahakitrungruang T; Tee MK; Rattanachartnarong N; Shotelersuk V; Suphapeetiporn K; Miller WL
    Horm Res Paediatr; 2010; 73(5):349-54. PubMed ID: 20389105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nephrogenic syndrome of inappropriate antidiuresis: a novel disorder in water balance in pediatric patients.
    Gitelman SE; Feldman BJ; Rosenthal SM
    Am J Med; 2006 Jul; 119(7 Suppl 1):S54-8. PubMed ID: 16843086
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
    Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
    J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vasopressin receptors and pharmacological chaperones: from functional rescue to promising therapeutic strategies.
    Mouillac B; Mendre C
    Pharmacol Res; 2014 May; 83():74-8. PubMed ID: 24239889
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological chaperones rescue cell-surface expression and function of misfolded V2 vasopressin receptor mutants.
    Morello JP; Salahpour A; Laperrière A; Bernier V; Arthus MF; Lonergan M; Petäjä-Repo U; Angers S; Morin D; Bichet DG; Bouvier M
    J Clin Invest; 2000 Apr; 105(7):887-95. PubMed ID: 10749568
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Rescue of a nephrogenic diabetes insipidus-causing vasopressin V2 receptor mutant by cell-penetrating peptides.
    Oueslati M; Hermosilla R; Schönenberger E; Oorschot V; Beyermann M; Wiesner B; Schmidt A; Klumperman J; Rosenthal W; Schülein R
    J Biol Chem; 2007 Jul; 282(28):20676-85. PubMed ID: 17491025
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Nephrogenic syndrome of inappropriate antidiuresis].
    Nawal B; Izzedine H; Haddiya I; Bentata Y
    Pan Afr Med J; 2019; 32():210. PubMed ID: 31312322
    [TBL] [Abstract][Full Text] [Related]  

  • 53. C112R, W323S, N317K mutations in the vasopressin V2 receptor gene in patients with nephrogenic diabetes insipidus. Mutations in brief no. 165. Online.
    Szalai C; Triga D; Czinner A
    Hum Mutat; 1998; 12(2):137-8. PubMed ID: 10694923
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM; Knoers NV
    Am J Med Sci; 1998 Nov; 316(5):300-9. PubMed ID: 9822112
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV; Deen PM
    Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vasopressin V2 receptor mutants that cause X-linked nephrogenic diabetes insipidus: analysis of expression, processing, and function.
    Oksche A; Schülein R; Rutz C; Liebenhoff U; Dickson J; Müller H; Birnbaumer M; Rosenthal W
    Mol Pharmacol; 1996 Oct; 50(4):820-8. PubMed ID: 8863826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasopressin V2 receptor, tolvaptan, and ERK1/2 phosphorylation in the renal collecting duct.
    Khan S; Raghuram V; Chen L; Chou CL; Yang CR; Khundmiri SJ; Knepper MA
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F57-F68. PubMed ID: 37916285
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemical validation and optimization of pharmacoperones targeting vasopressin type 2 receptor mutant.
    Janovick JA; Spicer TP; Bannister TD; Smith E; Ganapathy V; Scampavia L
    Biochem J; 2018 Sep; 475(18):2941-2953. PubMed ID: 30068530
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Novel vasopressin type 2 (AVPR2) gene mutations in Brazilian nephrogenic diabetes insipidus patients.
    Boson WL; Della Manna T; Damiani D; Miranda DM; Gadelha MR; Liberman B; Correa H; Romano-Silva MA; Friedman E; Silva FF; Ribeiro PA; De Marco L
    Genet Test; 2006; 10(3):157-62. PubMed ID: 17020465
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Nephrogenic diabetes insipidus.
    Bichet DG
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.